Rationale and strategies for the development of safe and effective optimized AAV vectors for human gene therapy
出版年份 2023 全文链接
标题
Rationale and strategies for the development of safe and effective optimized AAV vectors for human gene therapy
作者
关键词
-
出版物
Molecular Therapy-Nucleic Acids
Volume 32, Issue -, Pages 949-959
出版商
Elsevier BV
发表日期
2023-05-17
DOI
10.1016/j.omtn.2023.05.014
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Magenta Halts Development, Pursues Strategic Alternatives After Patient Death
- (2023) Alex Philippidis HUMAN GENE THERAPY
- Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B
- (2023) Steven W. Pipe et al. NEW ENGLAND JOURNAL OF MEDICINE
- Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A
- (2023) Johnny Mahlangu et al. NEW ENGLAND JOURNAL OF MEDICINE
- After Patient Death, FDA Places Hold on Pfizer Duchenne Muscular Dystrophy Gene Therapy Trial
- (2022) Alex Philippidis HUMAN GENE THERAPY
- Safety and activity of an engineered, liver-tropic adeno-associated virus vector expressing a hyperactive Padua factor IX administered with prophylactic glucocorticoids in patients with haemophilia B: a single-centre, single-arm, phase 1, pilot trial
- (2022) Feng Xue et al. Lancet Haematology
- Fatal Thrombotic Microangiopathy Case following Adeno-Associated Viral SMN Gene Therapy
- (2022) Julia Guillou et al. Blood Advances
- Phase 1–2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B
- (2022) Pratima Chowdary et al. NEW ENGLAND JOURNAL OF MEDICINE
- AAV vectors: The Rubik’s cube of human gene therapy
- (2022) Amaury Pupo et al. MOLECULAR THERAPY
- Deep diversification of an AAV capsid protein by machine learning
- (2021) Drew H. Bryant et al. NATURE BIOTECHNOLOGY
- Cas9-AAV6 gene correction of beta-globin in autologous HSCs improves sickle cell disease erythropoiesis in mice
- (2021) Adam C. Wilkinson et al. Nature Communications
- Engineered adeno-associated virus 3 vector with reduced reactivity to serum antibodies
- (2021) Mika Ito et al. Scientific Reports
- Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species
- (2021) Mohammadsharif Tabebordbar et al. CELL
- Coagulation Factor IX Gene Transfer to Non-human Primates Using Engineered AAV3 Capsid and Hepatic Optimized Expression Cassette
- (2021) Sandeep R.P. Kumar et al. Molecular Therapy-Methods & Clinical Development
- Hematopoietic stem cell gene editing and expansion: State-of-the-art technologies and recent applications
- (2021) Myriam L.R. Haltalli et al. EXPERIMENTAL HEMATOLOGY
- Rational engineering of a functional CpG-free ITR for AAV gene therapy
- (2021) Xiufang Pan et al. GENE THERAPY
- Multiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A
- (2021) Lindsey A. George et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adeno-Associated Virus Serotype-Specific Inverted Terminal Repeat Sequence Role in Vector Transgene Expression
- (2020) Lauriel F. Earley et al. HUMAN GENE THERAPY
- Engineering adeno-associated virus vectors for gene therapy
- (2020) Chengwen Li et al. NATURE REVIEWS GENETICS
- AAV3-miRNA vectors for growth suppression of human hepatocellular carcinoma cells in vitro and human liver tumors in a murine xenograft model in vivo
- (2020) Ling Yin et al. GENE THERAPY
- Adeno-Associated Virus D-Sequence-Mediated Suppression of Expression of a Human Major Histocompatibility Class II Gene: Implications in the Development of Adeno-Associated Virus Vectors for Modulating Humoral Immune Response
- (2020) Hyung-Joo Kwon et al. HUMAN GENE THERAPY
- IgG-cleaving endopeptidase enables in vivo gene therapy in the presence of anti-AAV neutralizing antibodies
- (2020) Christian Leborgne et al. NATURE MEDICINE
- Letter to the Editor
- (2020) Perry B. Shieh et al. HUMAN GENE THERAPY
- Moving Forward After Two Deaths in a Gene Therapy Trial of Myotubular Myopathy
- (2020) James M. Wilson et al. HUMAN GENE THERAPY
- AAV Vectors: Are They Safe?
- (2020) Arun Srivastava HUMAN GENE THERAPY
- Development of a Clinical Candidate AAV3 Vector for Gene Therapy of Hemophilia B
- (2020) Harrison C. Brown et al. HUMAN GENE THERAPY
- Enhanced Transduction of Human Hematopoietic Stem Cells by AAV6 Vectors: Implications in Gene Therapy and Genome Editing
- (2020) Hua Yang et al. Molecular Therapy-Nucleic Acids
- BAX 335 hemophilia B gene therapy clinical trial results - potential impact of CpG sequences on gene expression
- (2020) Barbara A Konkle et al. BLOOD
- Rescuing AAV gene transfer from neutralizing antibodies with an IgG-degrading enzyme
- (2020) Zachary C. Elmore et al. JCI Insight
- Current Clinical Applications of In Vivo Gene Therapy with AAVs
- (2020) Jerry R. Mendell et al. MOLECULAR THERAPY
- Engineering and In Vitro Selection of a Novel AAV3B Variant with High Hepatocyte Tropism and Reduced Seroreactivity
- (2020) Moanaro Biswas et al. Molecular Therapy-Methods & Clinical Development
- Adeno-associated virus vector as a platform for gene therapy delivery
- (2019) Dan Wang et al. NATURE REVIEWS DRUG DISCOVERY
- Protease-Activatable Adeno-Associated Virus Vector for Gene Delivery to Damaged Heart Tissue
- (2019) Caitlin M. Guenther et al. MOLECULAR THERAPY
- Highly Efficient and Marker-free Genome Editing of Human Pluripotent Stem Cells by CRISPR-Cas9 RNP and AAV6 Donor-Mediated Homologous Recombination
- (2019) Renata M. Martin et al. Cell Stem Cell
- Editing the Sickle Cell Disease Mutation in Primary Human Hematopoietic Stem Cells: Comparison of Endonucleases and Homologous Donor Templates
- (2019) Zulema Romero et al. MOLECULAR THERAPY
- Next Generation of Adeno-Associated Virus Vectors for Gene Therapy for Human Liver Diseases
- (2019) Kenneth I. Berns et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- Recombinant Adeno-Associated Virus Gene Therapy in Light of Luxturna (and Zolgensma and Glybera): Where Are We, and How Did We Get Here?
- (2019) Allison M. Keeler et al. Annual Review of Virology
- AAV6 Is Superior to Clade F AAVs in Stimulating Homologous Recombination-Based Genome Editing in Human HSPCs
- (2019) Amanda M. Dudek et al. MOLECULAR THERAPY
- Comprehensive AAV capsid fitness landscape reveals a viral gene and enables machine-guided design
- (2019) Pierce J. Ogden et al. SCIENCE
- Molecular characterization of novel Adeno-associated virus variants infecting human tissues
- (2019) Nishtha Purohit et al. VIRUS RESEARCH
- Global Transcriptional Response to CRISPR/Cas9-AAV6-Based Genome Editing in CD34 + Hematopoietic Stem and Progenitor Cells
- (2018) M. Kyle Cromer et al. MOLECULAR THERAPY
- Bioengineered AAV Capsids with Combined High Human Liver Transduction In Vivo and Unique Humoral Seroreactivity
- (2018) Nicole K. Paulk et al. MOLECULAR THERAPY
- Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
- (2017) Jerry R. Mendell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant
- (2017) Lindsey A. George et al. NEW ENGLAND JOURNAL OF MEDICINE
- AAV5–Factor VIII Gene Transfer in Severe Hemophilia A
- (2017) Savita Rangarajan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gene Therapy for Leber Hereditary Optic Neuropathy
- (2017) John Guy et al. OPHTHALMOLOGY
- Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6
- (2017) Rasmus O Bak et al. eLife
- Regulatory T cells and TLR9 activation shape antibody formation to a secreted transgene product in AAV muscle gene transfer
- (2017) Roland W. Herzog et al. CELLULAR IMMUNOLOGY
- A Precise Chemical Strategy To Alter the Receptor Specificity of the Adeno-Associated Virus
- (2016) Rachel E. Kelemen et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Adeno-Associated Virus: The Naturally Occurring Virus Versus the Recombinant Vector
- (2016) Arun Srivastava HUMAN GENE THERAPY
- Superior In vivo Transduction of Human Hepatocytes Using Engineered AAV3 Capsid
- (2016) Koen Vercauteren et al. MOLECULAR THERAPY
- Gene Therapy for Leber Hereditary Optic Neuropathy
- (2016) William J. Feuer et al. OPHTHALMOLOGY
- Development of Optimized AAV Serotype Vectors for High-Efficiency Transduction at Further Reduced Doses
- (2016) Chen Ling et al. Human Gene Therapy Methods
- Revised Estimates for the Number of Human and Bacteria Cells in the Body
- (2016) Ron Sender et al. PLOS BIOLOGY
- High-Efficiency Transduction of Primary Human Hematopoietic Stem/Progenitor Cells by AAV6 Vectors: Strategies for Overcoming Donor-Variation and Implications in Genome Editing
- (2016) Chen Ling et al. Scientific Reports
- AAV ancestral reconstruction library enables selection of broadly infectious viral variants
- (2015) J Santiago-Ortiz et al. GENE THERAPY
- Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors
- (2015) Jianbin Wang et al. NATURE BIOTECHNOLOGY
- In Silico Reconstruction of the Viral Evolutionary Lineage Yields a Potent Gene Therapy Vector
- (2015) Eric Zinn et al. Cell Reports
- Site-Directed Mutagenesis of Surface-Exposed Lysine Residues Leads to Improved Transduction by AAV2, But Not AAV8, Vectors in Murine HepatocytesIn Vivo
- (2015) Baozheng Li et al. Human Gene Therapy Methods
- Evaluation of Readministration of a Recombinant Adeno-Associated Virus Vector Expressing Acid Alpha-Glucosidase in Pompe Disease: Preclinical to Clinical Planning
- (2015) Manuela Corti et al. Human Gene Therapy Clinical Development
- Enhanced Transgene Expression from Recombinant Single-Stranded D-Sequence-Substituted Adeno-Associated Virus Vectors in Human Cell LinesIn Vitroand in Murine HepatocytesIn Vivo
- (2014) Chen Ling et al. JOURNAL OF VIROLOGY
- Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial
- (2014) Robert E MacLaren et al. LANCET
- Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B
- (2014) Amit C. Nathwani et al. NEW ENGLAND JOURNAL OF MEDICINE
- B-cell depletion is protective against anti-AAV capsid immune response: a human subject case study
- (2014) M Corti et al. Molecular Therapy-Methods & Clinical Development
- Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cells
- (2013) A. T. Martino et al. BLOOD
- Optimizing the transduction efficiency of capsid-modified AAV6 serotype vectors in primary human hematopoietic stem cells in vitro and in a xenograft mouse model in vivo
- (2013) Liujiang Song et al. CYTOTHERAPY
- My Life with Adeno-Associated Virus: A Long Time Spent Studying a Short Genome
- (2013) Kenneth I. Berns DNA AND CELL BIOLOGY
- Selection and evaluation of clinically relevant AAV variants in a xenograft liver model
- (2013) Leszek Lisowski et al. NATURE
- High-Efficiency Transduction of Primary Human Hematopoietic Stem Cells and Erythroid Lineage-Restricted Expression by Optimized AAV6 Serotype Vectors In Vitro and in a Murine Xenograft Model In Vivo
- (2013) Liujiang Song et al. PLoS One
- Optimization of the Capsid of Recombinant Adeno-Associated Virus 2 (AAV2) Vectors: The Final Threshold?
- (2013) George V. Aslanidi et al. PLoS One
- Targeted Modifications in Adeno-Associated Virus Serotype 8 Capsid Improves Its Hepatic Gene Transfer Efficiency In Vivo
- (2013) Dwaipayan Sen et al. Human Gene Therapy Methods
- Bioengineering of AAV2 Capsid at Specific Serine, Threonine, or Lysine Residues Improves Its Transduction Efficiency in Vitro and in Vivo
- (2013) Nishanth Gabriel et al. Human Gene Therapy Methods
- Gene Therapy for Aromatic L-Amino Acid Decarboxylase Deficiency
- (2012) W.-L. Hwu et al. Science Translational Medicine
- High-efficiency transduction of human monocyte-derived dendritic cells by capsid-modified recombinant AAV2 vectors
- (2012) George V. Aslanidi et al. VACCINE
- The genome of self-complementary adeno-associated viral vectors increases Toll-like receptor 9-dependent innate immune responses in the liver
- (2011) A. T. Martino et al. BLOOD
- Novel random peptide libraries displayed on AAV serotype 9 for selection of endothelial cell-directed gene transfer vectors
- (2011) K Varadi et al. GENE THERAPY
- Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B
- (2011) Amit C. Nathwani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human Hepatocyte Growth Factor Receptor Is a Cellular Coreceptor for Adeno-Associated Virus Serotype 3
- (2010) Chen Ling et al. HUMAN GENE THERAPY
- High-efficiency Transduction and Correction of Murine Hemophilia B Using AAV2 Vectors Devoid of Multiple Surface-exposed Tyrosines
- (2010) David M Markusic et al. MOLECULAR THERAPY
- A muscle-targeting peptide displayed on AAV2 improves muscle tropism on systemic delivery
- (2009) C-Y Yu et al. GENE THERAPY
- Directed evolution of adeno-associated virus for glioma cell transduction
- (2009) Casey A. Maguire et al. JOURNAL OF NEURO-ONCOLOGY
- AAV3-mediated transfer and expression of the pyruvate dehydrogenase E1 alpha subunit gene causes metabolic remodeling and apoptosis of human liver cancer cells
- (2009) Lyudmyla G. Glushakova et al. MOLECULAR GENETICS AND METABOLISM
- Generation of Novel AAV Variants by Directed Evolution for Improved CFTR Delivery to Human Ciliated Airway Epithelium
- (2009) Wuping Li et al. MOLECULAR THERAPY
- A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection
- (2009) L. Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Intramuscular Administration of AAV1-Lipoprotein Lipase S447X Lowers Triglycerides in Lipoprotein Lipase–Deficient Patients
- (2008) Erik S. Stroes et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Optimization of Recombinant Adeno-Associated Viral Vectors for Human β-Globin Gene Transfer and Transgene Expression
- (2008) Njeri Maina et al. HUMAN GENE THERAPY
- Treatment of Leber Congenital Amaurosis Due to RPE65 Mutations by Ocular Subretinal Injection of Adeno-Associated Virus Gene Vector: Short-Term Results of a Phase I Trial
- (2008) William W. Hauswirth et al. HUMAN GENE THERAPY
- Complement Is an Essential Component of the Immune Response to Adeno-Associated Virus Vectors
- (2008) A. K. Zaiss et al. JOURNAL OF VIROLOGY
- In Vitro and In Vivo Gene Therapy Vector Evolution via Multispecies Interbreeding and Retargeting of Adeno-Associated Viruses
- (2008) D. Grimm et al. JOURNAL OF VIROLOGY
- Engineering and Selection of Shuffled AAV Genomes: A New Strategy for Producing Targeted Biological Nanoparticles
- (2008) Wuping Li et al. MOLECULAR THERAPY
- DNA Shuffling of Adeno-associated Virus Yields Functionally Diverse Viral Progeny
- (2008) James T Koerber et al. MOLECULAR THERAPY
- Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
- (2008) Albert M. Maguire et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Gene Therapy on Visual Function in Leber's Congenital Amaurosis
- (2008) James W.B. Bainbridge et al. NEW ENGLAND JOURNAL OF MEDICINE
- Next generation of adeno-associated virus 2 vectors: Point mutations in tyrosines lead to high-efficiency transduction at lower doses
- (2008) L. Zhong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tyrosine-phosphorylation of AAV2 vectors and its consequences on viral intracellular trafficking and transgene expression
- (2008) Li Zhong et al. VIROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started